Mia Rodziewicz
Overview
Explore the profile of Mia Rodziewicz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
39
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dyball S, Madenidou A, Rodziewicz M, Reynolds J, Herrick A, Haque S, et al.
Semin Arthritis Rheum
. 2024 May;
67:152463.
PMID: 38796923
Introduction: Classification criteria aim to identify a homogenous population of patients for research. We aimed to quantify how well phase-III trials in connective tissue diseases (CTDs) represent a real-world cohort....
2.
Hannah J, Rodziewicz M, Mehta P, Heenan K, Ball E, Barratt S, et al.
Rheumatol Adv Pract
. 2024 May;
8(2):rkae056.
PMID: 38765189
Interstitial lung disease (ILD) is a significant complication of many systemic autoimmune rheumatic diseases (SARDs), although the clinical presentation, severity and outlook may vary widely between individuals. Despite the prevalence,...
3.
Rodziewicz M, Dyball S, Lunt M, McDonald S, Sutton E, Parker B, et al.
Lancet Rheumatol
. 2024 Jan;
5(5):e284-e292.
PMID: 38251591
Background: Patients with systemic lupus erythematosus (SLE) are at an increased risk of infection relative to the general population. We aimed to describe the frequency and risk factors for serious...
4.
Rodziewicz M, Mendoza-Pinto C, Dyball S, Munguia-Realpozo P, Parker B, Bruce I
Semin Arthritis Rheum
. 2024 Jan;
65:152346.
PMID: 38185077
Background: Anti-C20 monoclonal antibodies (MAb), such as rituximab, are commonly used for the treatment of patients with severe or refractory systemic lupus erythematosus (SLE) but clinical outcomes are highly variable....
5.
Rodziewicz M, Dyball S, Achieng S, Brix S, Parker B, Bruce I
Arthritis Rheumatol
. 2023 Sep;
76(2):315-316.
PMID: 37653671
No abstract available.
6.
Dyball S, Rodziewicz M, Mendoza-Pinto C, Bruce I, Parker B
Autoimmun Rev
. 2022 Aug;
21(11):103184.
PMID: 36031048
Purpose: Undifferentiated connective tissue disease (UCTD) encapsulates a broad range of conditions including incomplete forms of systemic lupus erythematosus (SLE) and systemic sclerosis (SSc), some of whom progress to a...
7.
Rodziewicz M, Dyball S, Bruce I, Parker B
Lancet Rheumatol
. 2021 Sep;
3(10):e683.
PMID: 34580663
No abstract available.
8.
Rodziewicz M, DCruz D
Ther Adv Musculoskelet Dis
. 2020 Jun;
12:1759720X20910855.
PMID: 32523633
Antiphospholipid syndrome (APS) is a systemic autoimmune disorder characterized by recurrent venous or arterial thrombosis with or without pregnancy morbidity in the presence of persistent antiphospholipid (aPL) autoantibodies. Anticoagulation has,...
9.
Rodziewicz M, Kiely P
Rheumatology (Oxford)
. 2018 May;
57(10):1866-1867.
PMID: 29796600
No abstract available.
10.
Rodziewicz M, Moreno-Otero R
Hepat Mon
. 2012 Jun;
12(4):294-5.
PMID: 22690239
No abstract available.